Product description

Dormosedan gel is a alpha2-agonist oromucosal gel for use in horses only.

Active ingredients

Each mL of Dormosedan gel contains:

• Detomidine hydrochloride 7.6 mg

Indications for use

Dormosedan gel is indicated for sedation and restraint in horses.

Administration and dosage

• Dormosedan gel produces sedation when administered sublingually at 0.018 mg/lb (0.040 mg/kg).

• Dormosedan gel must be placed beneath the tongue of the horse and is not meant to be swallowed.

• The dosing syringe delivers the product in 0.25 mL increments. The following dosing table may be used to determine the correct dose of Dormosedan gel.

• Sublingual dosing:

• Use impermeable gloves when handling the product. Remove the syringe from the outer carton. While holding the plunger, turn the ringstop on the plunger until the ring is able to slide freely up and down the plunger.

• Position the ring in such a way that the side nearest the barrel is at the desired volume marking. Turn the ring to secure it in place.

• Make sure that the horse’s mouth contains no feed.

• Remove the cap from the tip of the syringe and save for cap replacement.

• Insert the syringe tip into the horse’s mouth from the side of the mouth, placing the syringe tip beneath the tongue at the level of the commissure of the mouth.

• Depress the plunger until the ring-stop contacts the barrel, depositing the product beneath the tongue.

Prescribing information